Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) Stock Competitors & Peer Comparison
See NNNN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NNNN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NNNN | $3.90 | +2.50% | 174.8M | 26.55 | $0.15 | N/A |
| ISRG | $442.70 | -1.63% | 155.8B | 46.73 | $9.62 | N/A |
| BDX | $215.17 | +1.20% | 58.4B | 16.50 | $13.00 | +1.86% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +1.86% |
| MDLN | $40.73 | -0.44% | 37B | 30.89 | $1.36 | N/A |
| RMD | $241.15 | +3.30% | 33.6B | 20.69 | $11.53 | +1.06% |
| WST | $412.42 | -0.03% | 28.8B | 44.88 | $9.20 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $88.85 | -1.37% | 15.1B | 12.48 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +1.86% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
NNNN vs ISRG Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ISRG has a market cap of 155.8B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ISRG trades at $442.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ISRG's P/E ratio is 46.73. In terms of profitability, NNNN's ROE is +0.27%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, NNNN is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDX)
NNNN vs BDX Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BDX has a market cap of 58.4B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BDX trades at $215.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BDX's P/E ratio is 16.50. In terms of profitability, NNNN's ROE is +0.27%, compared to BDX's ROE of +0.04%. Regarding short-term risk, NNNN is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
NNNN vs BDXA Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BDXA's P/E ratio is 45.70. In terms of profitability, NNNN's ROE is +0.27%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, NNNN is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
NNNN vs MDLN Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, MDLN has a market cap of 37B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while MDLN trades at $40.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas MDLN's P/E ratio is 30.89. In terms of profitability, NNNN's ROE is +0.27%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, NNNN is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check MDLN's competition here
ResMed Inc. (NYSE: RMD)
NNNN vs RMD Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, RMD has a market cap of 33.6B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while RMD trades at $241.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas RMD's P/E ratio is 20.69. In terms of profitability, NNNN's ROE is +0.27%, compared to RMD's ROE of +0.25%. Regarding short-term risk, NNNN is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check RMD's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
NNNN vs WST Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, WST has a market cap of 28.8B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while WST trades at $412.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas WST's P/E ratio is 44.88. In terms of profitability, NNNN's ROE is +0.27%, compared to WST's ROE of +0.21%. Regarding short-term risk, NNNN is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
NNNN vs HOLX Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas HOLX's P/E ratio is 31.54. In terms of profitability, NNNN's ROE is +0.27%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, NNNN is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
NNNN vs SOLV Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, SOLV has a market cap of 15.1B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while SOLV trades at $88.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas SOLV's P/E ratio is 12.48. In terms of profitability, NNNN's ROE is +0.27%, compared to SOLV's ROE of +0.03%. Regarding short-term risk, NNNN is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
NNNN vs BDXB Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BDXB's P/E ratio is 7.60. In terms of profitability, NNNN's ROE is +0.27%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, NNNN is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
NNNN vs BAX Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BAX has a market cap of 13.6B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BAX trades at $25.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BAX's P/E ratio is 12.66. In terms of profitability, NNNN's ROE is +0.27%, compared to BAX's ROE of -0.12%. Regarding short-term risk, NNNN is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
NNNN vs COO Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, COO has a market cap of 12B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while COO trades at $62.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas COO's P/E ratio is 13.80. In terms of profitability, NNNN's ROE is +0.27%, compared to COO's ROE of +0.07%. Regarding short-term risk, NNNN is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
NNNN vs RGEN Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, RGEN has a market cap of 11B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while RGEN trades at $166.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas RGEN's P/E ratio is 95.86. In terms of profitability, NNNN's ROE is +0.27%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, NNNN is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
NNNN vs AVTR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, AVTR has a market cap of 10.7B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while AVTR trades at $15.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas AVTR's P/E ratio is 18.50. In terms of profitability, NNNN's ROE is +0.27%, compared to AVTR's ROE of +0.06%. Regarding short-term risk, NNNN is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
NNNN vs ATR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ATR has a market cap of 9.1B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ATR trades at $141.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ATR's P/E ratio is 25.01. In terms of profitability, NNNN's ROE is +0.27%, compared to ATR's ROE of +0.10%. Regarding short-term risk, NNNN is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
NNNN vs BLCO Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BLCO has a market cap of 7.6B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BLCO trades at $21.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BLCO's P/E ratio is 32.78. In terms of profitability, NNNN's ROE is +0.27%, compared to BLCO's ROE of -0.02%. Regarding short-term risk, NNNN is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
NNNN vs TFX Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, TFX has a market cap of 6.2B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while TFX trades at $153.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas TFX's P/E ratio is 17.87. In terms of profitability, NNNN's ROE is +0.27%, compared to TFX's ROE of +0.10%. Regarding short-term risk, NNNN is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
NNNN vs MMSI Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, MMSI has a market cap of 5.3B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while MMSI trades at $87.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas MMSI's P/E ratio is 22.52. In terms of profitability, NNNN's ROE is +0.27%, compared to MMSI's ROE of +0.10%. Regarding short-term risk, NNNN is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
NNNN vs ICUI Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ICUI has a market cap of 4.5B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ICUI trades at $178.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ICUI's P/E ratio is 22.25. In terms of profitability, NNNN's ROE is +0.27%, compared to ICUI's ROE of +0.03%. Regarding short-term risk, NNNN is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
NNNN vs PLSE Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, PLSE has a market cap of 4.2B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while PLSE trades at $54.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas PLSE's P/E ratio is -48.29. In terms of profitability, NNNN's ROE is +0.27%, compared to PLSE's ROE of -0.78%. Regarding short-term risk, NNNN is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check PLSE's competition here
Envista Holdings Corp (NYSE: NVST)
NNNN vs NVST Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, NVST has a market cap of 4.1B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while NVST trades at $24.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas NVST's P/E ratio is 17.21. In terms of profitability, NNNN's ROE is +0.27%, compared to NVST's ROE of +0.21%. Regarding short-term risk, NNNN is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check NVST's competition here
Stevanato Group S.p.A. (NYSE: STVN)
NNNN vs STVN Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, STVN has a market cap of 3.8B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while STVN trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas STVN's P/E ratio is 20.95. In terms of profitability, NNNN's ROE is +0.27%, compared to STVN's ROE of +0.09%. Regarding short-term risk, NNNN is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check STVN's competition here
AtriCure, Inc. (NASDAQ: ATRC)
NNNN vs ATRC Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ATRC trades at $56.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ATRC's P/E ratio is 1786.65. In terms of profitability, NNNN's ROE is +0.27%, compared to ATRC's ROE of +0.03%. Regarding short-term risk, NNNN is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ATRC's competition here
Azenta, Inc. (NASDAQ: AZTA)
NNNN vs AZTA Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, AZTA has a market cap of 2.1B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while AZTA trades at $45.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas AZTA's P/E ratio is 116.43. In terms of profitability, NNNN's ROE is +0.27%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, NNNN is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check AZTA's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
NNNN vs XRAY Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while XRAY trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas XRAY's P/E ratio is 6.83. In terms of profitability, NNNN's ROE is +0.27%, compared to XRAY's ROE of -0.09%. Regarding short-term risk, NNNN is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check XRAY's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
NNNN vs BLFS Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BLFS's P/E ratio is 37.49. In terms of profitability, NNNN's ROE is +0.27%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, NNNN is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
NNNN vs KMTS Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, KMTS has a market cap of 1.9B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while KMTS trades at $29.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas KMTS's P/E ratio is -11.94. In terms of profitability, NNNN's ROE is +0.27%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, NNNN is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check KMTS's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
NNNN vs LMAT Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while LMAT trades at $78.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas LMAT's P/E ratio is 29.15. In terms of profitability, NNNN's ROE is +0.27%, compared to LMAT's ROE of +0.15%. Regarding short-term risk, NNNN is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check LMAT's competition here
STAAR Surgical Company (NASDAQ: STAA)
NNNN vs STAA Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while STAA trades at $27.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas STAA's P/E ratio is 46.82. In terms of profitability, NNNN's ROE is +0.27%, compared to STAA's ROE of +0.00%. Regarding short-term risk, NNNN is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
NNNN vs ATRI Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ATRI's P/E ratio is 64.50. In terms of profitability, NNNN's ROE is +0.27%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, NNNN is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
NNNN vs ANGO Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ANGO has a market cap of 522.3M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ANGO trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ANGO's P/E ratio is -31.85. In terms of profitability, NNNN's ROE is +0.27%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, NNNN is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
NNNN vs MMEDV Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas MMEDV's P/E ratio is N/A. In terms of profitability, NNNN's ROE is +0.27%, compared to MMEDV's ROE of N/A. Regarding short-term risk, NNNN is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
NNNN vs EMBC Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, EMBC has a market cap of 370M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while EMBC trades at $6.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas EMBC's P/E ratio is 2.51. In terms of profitability, NNNN's ROE is +0.27%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, NNNN is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
NNNN vs SMTI Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, SMTI has a market cap of 290.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while SMTI trades at $32.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas SMTI's P/E ratio is -526.83. In terms of profitability, NNNN's ROE is +0.27%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, NNNN is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
NNNN vs OSUR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, OSUR has a market cap of 245.5M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while OSUR trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas OSUR's P/E ratio is -5.16. In terms of profitability, NNNN's ROE is +0.27%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, NNNN is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check OSUR's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
NNNN vs PDEX Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, PDEX has a market cap of 228.8M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while PDEX trades at $69.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas PDEX's P/E ratio is 19.59. In terms of profitability, NNNN's ROE is +0.27%, compared to PDEX's ROE of +0.26%. Regarding short-term risk, NNNN is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check PDEX's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
NNNN vs UTMD Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, UTMD has a market cap of 208.1M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while UTMD trades at $73.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas UTMD's P/E ratio is 21.61. In terms of profitability, NNNN's ROE is +0.27%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, NNNN is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check UTMD's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
NNNN vs KRMD Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, KRMD has a market cap of 178.7M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while KRMD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas KRMD's P/E ratio is -97.25. In terms of profitability, NNNN's ROE is +0.27%, compared to KRMD's ROE of -0.00%. Regarding short-term risk, NNNN is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
NNNN vs STXS Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, STXS has a market cap of 90.2M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while STXS trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas STXS's P/E ratio is -5.29. In terms of profitability, NNNN's ROE is +0.27%, compared to STXS's ROE of -1.16%. Regarding short-term risk, NNNN is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
NNNN vs AKYA Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas AKYA's P/E ratio is -1.34. In terms of profitability, NNNN's ROE is +0.27%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, NNNN is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check AKYA's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
NNNN vs POCI Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, POCI has a market cap of 55.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while POCI trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas POCI's P/E ratio is -10.98. In terms of profitability, NNNN's ROE is +0.27%, compared to POCI's ROE of -0.24%. Regarding short-term risk, NNNN is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check POCI's competition here
SkyAI, Inc. (NASDAQ: STSS)
NNNN vs STSS Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas STSS's P/E ratio is -0.02. In terms of profitability, NNNN's ROE is +0.27%, compared to STSS's ROE of -0.99%. Regarding short-term risk, NNNN is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
NNNN vs OMIC Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas OMIC's P/E ratio is -0.58. In terms of profitability, NNNN's ROE is +0.27%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, NNNN is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
NNNN vs IGAP Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas IGAP's P/E ratio is -10.52. In terms of profitability, NNNN's ROE is +0.27%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, NNNN is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check IGAP's competition here
Daxor Corporation (NASDAQ: DXR)
NNNN vs DXR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, DXR has a market cap of 49.3M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while DXR trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas DXR's P/E ratio is 6.86. In terms of profitability, NNNN's ROE is +0.27%, compared to DXR's ROE of +0.13%. Regarding short-term risk, NNNN is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check DXR's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
NNNN vs HBIO Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, HBIO has a market cap of 44.1M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while HBIO trades at $9.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas HBIO's P/E ratio is -26.89. In terms of profitability, NNNN's ROE is +0.27%, compared to HBIO's ROE of -1.30%. Regarding short-term risk, NNNN is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check HBIO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
NNNN vs ZJYL Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ZJYL has a market cap of 38.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ZJYL trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ZJYL's P/E ratio is 33.58. In terms of profitability, NNNN's ROE is +0.27%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, NNNN is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check ZJYL's competition here
Nephros, Inc. (NASDAQ: NEPH)
NNNN vs NEPH Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, NEPH has a market cap of 33.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while NEPH trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas NEPH's P/E ratio is 51.17. In terms of profitability, NNNN's ROE is +0.27%, compared to NEPH's ROE of +0.17%. Regarding short-term risk, NNNN is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
NNNN vs SDC Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas SDC's P/E ratio is -0.03. In terms of profitability, NNNN's ROE is +0.27%, compared to SDC's ROE of -1.96%. Regarding short-term risk, NNNN is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
NNNN vs MLSS Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, MLSS has a market cap of 27.9M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while MLSS trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas MLSS's P/E ratio is -6.15. In terms of profitability, NNNN's ROE is +0.27%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, NNNN is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
NNNN vs IVC Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas IVC's P/E ratio is -0.79. In terms of profitability, NNNN's ROE is +0.27%, compared to IVC's ROE of -0.46%. Regarding short-term risk, NNNN is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
NNNN vs RVP Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, RVP has a market cap of 16.6M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while RVP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas RVP's P/E ratio is -4.62. In terms of profitability, NNNN's ROE is +0.27%, compared to RVP's ROE of -0.05%. Regarding short-term risk, NNNN is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
NNNN vs BNGO Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, BNGO has a market cap of 13M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while BNGO trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas BNGO's P/E ratio is -0.36. In terms of profitability, NNNN's ROE is +0.27%, compared to BNGO's ROE of -0.85%. Regarding short-term risk, NNNN is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
NNNN vs FEMY Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, FEMY has a market cap of 12.6M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while FEMY trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas FEMY's P/E ratio is -0.33. In terms of profitability, NNNN's ROE is +0.27%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, NNNN is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
NNNN vs RGNT Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, RGNT has a market cap of 8.9M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while RGNT trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas RGNT's P/E ratio is -0.52. In terms of profitability, NNNN's ROE is +0.27%, compared to RGNT's ROE of N/A. Regarding short-term risk, NNNN is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
NNNN vs LUCY Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, LUCY has a market cap of 7.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while LUCY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas LUCY's P/E ratio is -0.65. In terms of profitability, NNNN's ROE is +0.27%, compared to LUCY's ROE of -1.03%. Regarding short-term risk, NNNN is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
NNNN vs NSTG Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas NSTG's P/E ratio is -0.03. In terms of profitability, NNNN's ROE is +0.27%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, NNNN is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
NNNN vs CUPR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, CUPR has a market cap of 4.6M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while CUPR trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas CUPR's P/E ratio is -1.24. In terms of profitability, NNNN's ROE is +0.27%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, NNNN is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
NNNN vs POAI Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas POAI's P/E ratio is -0.38. In terms of profitability, NNNN's ROE is +0.27%, compared to POAI's ROE of -21.19%. Regarding short-term risk, NNNN is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
NNNN vs MHUA Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas MHUA's P/E ratio is 0.25. In terms of profitability, NNNN's ROE is +0.27%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, NNNN is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
NNNN vs NXGL Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, NXGL has a market cap of 2M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while NXGL trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas NXGL's P/E ratio is -5.84. In terms of profitability, NNNN's ROE is +0.27%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, NNNN is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
NNNN vs GMVD Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas GMVD's P/E ratio is -0.01. In terms of profitability, NNNN's ROE is +0.27%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, NNNN is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
NNNN vs GMVDW Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas GMVDW's P/E ratio is N/A. In terms of profitability, NNNN's ROE is +0.27%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, NNNN is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
NNNN vs AVGR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas AVGR's P/E ratio is -0.05. In terms of profitability, NNNN's ROE is +0.27%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, NNNN is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
NNNN vs NXGLW Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, NXGLW has a market cap of 542.8K. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas NXGLW's P/E ratio is -0.01. In terms of profitability, NNNN's ROE is +0.27%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, NNNN is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
NNNN vs LUCYW Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas LUCYW's P/E ratio is N/A. In terms of profitability, NNNN's ROE is +0.27%, compared to LUCYW's ROE of -1.03%. Regarding short-term risk, NNNN is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for NNNN.Check LUCYW's competition here
Analogic Corporation (NASDAQ: ALOG)
NNNN vs ALOG Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ALOG's P/E ratio is 40.93. In terms of profitability, NNNN's ROE is +0.27%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, NNNN is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
NNNN vs IVTY Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas IVTY's P/E ratio is -3.80. In terms of profitability, NNNN's ROE is +0.27%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, NNNN is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check IVTY's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
NNNN vs ATRS Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas ATRS's P/E ratio is 14.95. In terms of profitability, NNNN's ROE is +0.27%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, NNNN is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check ATRS's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
NNNN vs HRC Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, HRC has a market cap of 0. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas HRC's P/E ratio is 41.92. In terms of profitability, NNNN's ROE is +0.27%, compared to HRC's ROE of +0.14%. Regarding short-term risk, NNNN is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check HRC's competition here
Apria, Inc. (NASDAQ: APR)
NNNN vs APR Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, APR has a market cap of 0. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas APR's P/E ratio is 22.59. In terms of profitability, NNNN's ROE is +0.27%, compared to APR's ROE of +9.81%. Regarding short-term risk, NNNN is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
NNNN vs IIN Comparison November 2026
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NNNN stands at 174.8M. In comparison, IIN has a market cap of 0. Regarding current trading prices, NNNN is priced at $3.90 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NNNN currently has a P/E ratio of 26.55, whereas IIN's P/E ratio is 226.45. In terms of profitability, NNNN's ROE is +0.27%, compared to IIN's ROE of -0.00%. Regarding short-term risk, NNNN is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for NNNN.Check IIN's competition here